Why edibles feel fundamentally different from smoked or vaped cannabis: the 11-hydroxy-THC conversion, first-pass metabolism, body high pharmacology, onset delay psychology, and the complete dosing guide to avoid common mistakes.
When cannabis is smoked or vaporized, THC enters the lungs and travels directly to the heart, then to the brain via systemic circulation. The entire journey takes 30–90 seconds. The THC that reaches the brain is the same delta-9-THC from the plant.
Edibles follow a completely different route. After ingestion, cannabis compounds must survive the stomach’s acidic environment, cross the intestinal wall, and travel through the hepatic portal vein to the liver — before ever reaching systemic circulation. This first-pass metabolism in the liver is where the fundamental transformation occurs.
Liver enzymes (primarily CYP2C9 and CYP3A4) convert delta-9-THC into 11-hydroxy-THC (11-OH-THC). This metabolite is not simply “THC lite” — it is a distinct psychoactive compound with its own pharmacological profile:
The delay between eating an edible and feeling effects is the source of more cannabis over-dosing incidents than any other factor. Understanding what causes the delay allows users to predict and manage their experience:
Gastric emptying rate: Cannabis compounds in an edible cannot be absorbed until the stomach empties its contents into the small intestine. A full stomach delays emptying; an empty stomach accelerates it. This is why edibles taken on an empty stomach can kick in in 30 minutes while the same edible after a large meal may take 2+ hours.
Intestinal absorption kinetics: THC must diffuse across the intestinal epithelium (passive absorption of a lipophilic compound). The fat content of the edible matters here — oil-soluble THC is absorbed better alongside dietary fats. This is why cannabis-infused butter and oil-based products have higher bioavailability than water-based beverages.
Hepatic first-pass metabolism: The conversion of delta-9-THC to 11-OH-THC in the liver adds time to the process and is highly variable between individuals. CYP enzyme activity varies by genetics, other medications, liver function, and even diet. Two people who eat the same edible may have dramatically different onset times and effect intensities due to CYP variant differences.
Individual factors: Body composition (fat stores sequester cannabinoids), tolerance level, gastrointestinal motility, and hydration all affect onset and intensity.
The most consistent user report about edibles is the quality of the high: it is more physical, more immersive, and often more psychedelic in character than an equivalent inhaled dose. Several mechanisms contribute to this qualitatively different experience:
| Dimension | Inhaled Cannabis | Edibles |
|---|---|---|
| Active compound | Delta-9-THC (primary) | 11-OH-THC (primary) + delta-9-THC |
| Onset | 30 seconds – 5 minutes | 30 – 120 minutes |
| Peak | 15–30 minutes | 2–4 hours |
| Duration | 1–3 hours | 4–8 hours (up to 12 at high doses) |
| High character | Cerebral, clear-headed, terpene-forward | Body-centric, immersive, psychedelic undertone |
| Controlability | High; can stop at any time | Low; once absorbed, cannot stop effects |
| Bioavailability | 31–56% | 6–20% (but 11-OH-THC potency compensates) |
| Terpene effects | Strong; terpenes preserve and contribute to character | Reduced; many terpenes degraded during cooking/processing |
The delay between consuming an edible and feeling effects is not just a pharmacokinetic fact — it is a psychological minefield that causes more bad edibles experiences than any other factor. The psychology works as follows:
At 45 minutes post-consumption with no felt effects, the user’s confidence in the dose wanes. They may have consumed with a full meal; they may be a first-time user with no reference point; they may have been sold under-dosed product in the past. The rational-feeling response is to take more.
The problem: the first dose is not lost. It is in transit through the GI system, being converted to 11-OH-THC in the liver, and is 60–90 minutes from peak effect. The second dose follows 90–120 minutes behind. The user who re-dosed at 60 minutes will face both doses peaking simultaneously 2–4 hours post-consumption, often at 2–4x their intended dose. This is the mechanism behind the vast majority of “I thought I was dying” edibles experiences.
The absolute rule: never re-dose within 2 hours of an edible. Ideally, wait the full 3–4 hours to fully evaluate the first dose before considering additional consumption.
| Experience Level | Recommended Dose | Expected Experience | Re-dose Wait |
|---|---|---|---|
| First time / cannabis naive | 2.5mg THC | Mild relaxation, possible subtle body warmth; minimal intoxication | 3–4 hours minimum |
| Occasional user | 5mg THC | Clear body high, mood elevation, possible mild psychedelic quality | 3 hours minimum |
| Regular user | 10–15mg THC | Strong body high, immersive experience, potential for psychedelic-adjacent states | 2.5 hours minimum |
| Experienced / high tolerance | 20–50mg THC | Intense, prolonged body high; deep sedation at higher doses; not for beginners | 3 hours minimum |
| Medical / high-dose | 50–100mg+ THC | Medical applications only (cancer pain, spasticity); requires established tolerance | Medical supervision recommended |
Many users describe edible highs as more visually engaging, more emotionally intense, and more reminiscent of psychedelic experiences than smoked or vaped cannabis at comparable THC doses. Research suggests several explanations:
5-HT2A activation hypothesis: Some researchers propose that 11-OH-THC may have greater affinity for 5-HT2A serotonin receptors (the primary target of classical psychedelics like psilocybin and LSD) than delta-9-THC. If confirmed, this would explain the visual and perceptual quality of high-dose edibles experiences.
Peak concentration vs. duration trade-off: Edibles produce a lower peak plasma concentration of cannabinoids but maintain that concentration for a much longer period. The sustained, gradual rise over 2–4 hours may allow brain regions to adapt to intermediate levels and then be overwhelmed by the continued buildup in a way that rapid-onset inhaled cannabis does not replicate.
Limbic system involvement: The body-centric heaviness and emotional intensity of edibles may reflect greater involvement of limbic system CB1 receptors, which receive prolonged cannabinoid exposure during the extended edibles peak.
An uncomfortable edibles experience is not medically dangerous for a healthy adult but can be deeply distressing. The following approaches are evidence-supported for managing overconsumption:
Different edible formats have different pharmacokinetic profiles due to varying absorption mechanisms:
Not all cannabis is equally suited for edibles use. The absence of terpene influence (many degrade during cooking or processing) means the cannabinoid profile dominates the edibles experience more than with inhaled cannabis. The following strain characteristics translate best to edibles:
| Strain | THC % | Edibles Character | Best Use Case |
|---|---|---|---|
| Blue Dream | 17–21% | Balanced body-head high; relaxed euphoria; low anxiety risk | Social occasions, daytime edibles, creative sessions |
| OG Kush | 20–26% | Strong body high, euphoric peaks; extended couch-lock in edibles | Evening, insomnia, pain management via edibles |
| Granddaddy Purple | 17–23% | Deep body sedation; linalool terpene flavour survives cooking; grape notes | Insomnia edibles; pain; evening deep relaxation |
| Jack Herer | 18–24% | Cerebral, creative edibles high; uplifting body effect | Daytime edibles; creative projects; social confidence |
| Harlequin | 6% / 10% CBD | Functional, anxiety-free edibles experience; mild body relaxation | First-time edibles users; anxiety-prone individuals; medical use |
The fat content of the edible itself significantly affects how much THC is absorbed. THC is highly lipophilic (fat-soluble); it binds to and is absorbed alongside dietary fat. This has practical implications for homemade edibles and commercial product selection:
Edibles have specific medical advantages that make them preferred over inhaled cannabis in certain clinical contexts:
Longer duration: For chronic pain, muscle spasticity, and insomnia, the 4–8 hour coverage of edibles is therapeutically superior to the 1–3 hour window of inhaled cannabis. A bedtime edible can provide pain relief and sleep support throughout the night without re-dosing.
Pulmonary disease: For patients with asthma, COPD, or other respiratory conditions, edibles provide cannabis therapy without inhalation of combustion byproducts or even warm vapor.
Precise consistent dosing: Commercial edibles provide exact, consistent THC doses in each unit — 5mg, 10mg gummies allow for precise titration not achievable with flower or concentrate.
Gastrointestinal conditions: IBD, Crohn’s disease, and IBS patients may benefit from orally-administered cannabinoids that can act locally in the GI tract before systemic absorption, providing both local anti-inflammatory effects and systemic symptom relief.
Related guides: All Cannabis Effects • Happy Effect • Couch-Lock Effect • Sedating Effect • Cannabis Anxiety • CBD Effects • Anxiety Relief